BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 12722126)

  • 1. Papanicolaou Society of Cytopathology guidelines for educational notes, disclaimers, and similar comments on reports of cervical cytology specimens.
    Papanicolau Society of Cytopathology Practice Guidelines Task Force
    Diagn Cytopathol; 2003 May; 28(5):282-5. PubMed ID: 12722126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of the College of American Pathologists' programs in surgical pathology and cytopathology. Data summary of diagnostic performance in cervical cytopathology.
    Penner DW
    Acta Cytol; 1989; 33(4):439-42. PubMed ID: 2750431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ["Papanicolaou." Outmoded, isn't it?].
    de León-Antoni E
    Bol Asoc Med P R; 1991 Oct; 83(10):462-4. PubMed ID: 1789893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assurance in cytopathology. Recommendations and ongoing quality assurance activities of the American Society of Clinical Pathologists.
    Bonfiglio TA
    Acta Cytol; 1989; 33(4):431-3. PubMed ID: 2750429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common problems in Papanicolaou smear interpretation.
    DeMay RM
    Arch Pathol Lab Med; 1997 Mar; 121(3):229-38. PubMed ID: 9111106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the state of the art and recommendations of the Papanicolaou Society of Cytopathology for urinary cytology procedures and reporting : the Papanicolaou Society of Cytopathology Practice Guidelines Task Force.
    Layfield LJ; Elsheikh TM; Fili A; Nayar R; Shidham V;
    Diagn Cytopathol; 2004 Jan; 30(1):24-30. PubMed ID: 14696141
    [No Abstract]   [Full Text] [Related]  

  • 7. European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology.
    Herbert A; Bergeron C; Wiener H; Schenck U; Klinkhamer P; Bulten J; Arbyn M
    Cytopathology; 2007 Aug; 18(4):213-9. PubMed ID: 17635161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality control in cytopathology applied to screening for cervical carcinoma.
    Marsan C
    Pol J Pathol; 1995; 46(4):245-8. PubMed ID: 8713292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytopathology laboratory improvement programs of the College of American Pathologists: Laboratory Accreditation Program (CAP LAP) and Performance Improvement Program in Cervicovaginal Cytology (CAP PAP).
    Nielsen ML
    Arch Pathol Lab Med; 1997 Mar; 121(3):256-9. PubMed ID: 9111112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does a zero error standard exist for the Papanicolaou smear? A pathologist's perspective.
    Frable WJ
    Arch Pathol Lab Med; 1997 Mar; 121(3):301-10. PubMed ID: 9111124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The false-negative fraction for Papanicolaou smears: how often are "abnormal" smears not detected by a "standard" screening cytologist?
    Naryshkin S
    Arch Pathol Lab Med; 1997 Mar; 121(3):270-2. PubMed ID: 9111116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blinded review of Papanicolaou smears.
    Gill GW
    Cancer; 2005 Apr; 105(2):53-5. PubMed ID: 15662699
    [No Abstract]   [Full Text] [Related]  

  • 13. ASCCP patient management guidelines: Pap test specimen adequacy and quality indicators.
    Davey DD; Austin RM; Birdsong G; Buck HW; Cox JT; Darragh TM; Elgert PA; Hanson V; Henry MR; Waldman J;
    Am J Clin Pathol; 2002 Nov; 118(5):714-8. PubMed ID: 12428791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening of cervical cancer, false negative vaginal smears].
    Weintraub D
    Rev Med Suisse Romande; 1997 Nov; 117(11):921. PubMed ID: 9471658
    [No Abstract]   [Full Text] [Related]  

  • 15. Liability issues with the Papanicolaou smear: a defense lawyer's perspective.
    Varner CD
    Arch Pathol Lab Med; 1997 Mar; 121(3):315-20. PubMed ID: 9111126
    [No Abstract]   [Full Text] [Related]  

  • 16. Education and training for cytopathologists. Its role in quality assurance.
    Parker JE
    Acta Cytol; 1989; 33(4):448-50. PubMed ID: 2750433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External quality control of cervical cytopathology: interlaboratory variability.
    Azara CZ; Manrique EJ; Alves de Souza NL; Rodrigues AR; Tavares SB; Amaral RG
    Acta Cytol; 2013; 57(6):585-90. PubMed ID: 24107687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme.
    Coleman D; Day N; Douglas G; Farmery E; Lynge E; Philip J; Segnan N
    Eur J Cancer; 1993; 29A Suppl 4():S1-38. PubMed ID: 8274301
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cervical cancer screening. False negative smears].
    Vassilakos P; De Marval F; Muñoz M
    Rev Med Suisse Romande; 1997 Aug; 117(8):597-601. PubMed ID: 9340714
    [No Abstract]   [Full Text] [Related]  

  • 20. Pitfalls in the screening and early diagnosis of cervical cancer.
    Wain GV; Hacker NF
    Curr Opin Obstet Gynecol; 1990 Feb; 2(1):74-9. PubMed ID: 2102310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.